ArticleAsian Pacific journal of cancer prevention : APJCP2026
Mechanistic Exploration of the anticancer activity of Justicia adhatoda Plant Leaf Ethanolic Extract against Colon Cancer Cells: An in silico and in vitro Approach.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nobiletin ameliorates diabetic nephropathy by modulating TP53-associated PANoptosis: an experimental study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveBeing the 3rd most prevalent cancer, colorectal cancer (CRC) has a high rate of mortality, a poor prognosis, and a clinical outcome. Treatment with commercial synthetic anti-cancer drugs also imparts a number of co-morbidities, further complicating the condition. Hence, there is a need to identify a potential anticancer agent to decrease the mortality rate and provide better clinical outcome in CRC patients. Pharmacologically active agents from natural sources are the currently recognized alternatives to synthetic drugs due to their minimal toxicity. In this study, a widely recognized plant, Justicia adhatoda (JA), traditionally used for treating respiratory ailments and rich in anti-inflammatory potential, was used to investigate its antiproliferative property against CRC. MATERIALS &
methodsPreliminary phytochemical screening, GCMS, Antioxidant assay, anti-inflammatory assay, cell culture -MTT assay, fluorescence staining assay, and protein and gene expression analysis.
resultsThe ethanolic extract of JA showed a strong cytotoxic effect on the cancer cells. The results of fluorescence staining show that the JA extract impart reactive oxygen species (ROS) -mediated apoptosis in proliferating cells by increasing ROS generation. This was further confirmed by evaluating the protein level of the antioxidant reservoirs and oxidative/inflammatory markers, which upon treatment were found to decrease and increase, respectively. This imbalance is attributed to the activation of the intrinsic apoptosis pathway, by altering the levels of pro- and anti- apoptotic genes in the cells and ultimately leading to cell death. The in silico analysis of pharmacokinetics, toxicity and molecular docking suggests that JA phytoconstituents show drug-like qualities and a promising activity against cancer.
conclusionOverall, the findings suggest that JA ethanolic extract could be an effective anticancer agent against HT-29 colon adenocarcinoma cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.